Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Planned sale President and CEO sold 390 shares at $9.99 ($3,896)
  2. 4 Planned sale President and CEO sold 1,332 shares at $5.81 ($7,739)
  3. 4 Planned sale President and CEO sold 17,808 shares at $5.13 ($91,355)
  4. 4 Planned sale Chief Financial Officer sold 4,135 shares at an average $5.13 ($21,202)
  5. 4 Open-market sale President and CEO sold 335 shares at $5.65 ($1,893)
  6. 4 Open-market sale Director sold 284 shares at $5.65 ($1,605)
  7. 4 Open-market sale Director sold 594 shares at $5.65 ($3,356)
  8. 4 Grant or award Director acquired 8,333 shares (grant or award)
  9. 4 Grant or award Director acquired 8,333 shares (grant or award)
  10. 4 Grant or award Director acquired 8,333 shares (grant or award)
  11. 4 Grant or award Director acquired 8,333 shares (grant or award)
  12. 4 Grant or award Director acquired 8,333 shares (grant or award)
  13. 4 Grant or award Director acquired 8,333 shares (grant or award)
  14. 4 Grant or award Director acquired 8,333 shares (grant or award)
  15. 4 Grant or award Director acquired 8,333 shares (grant or award)
  16. 4 Grant or award Director acquired 8,333 shares (grant or award)
  17. 4 Planned sale Chief Financial Officer sold 11,143 shares at $8.13 ($90,593)
  18. 4 Planned sale President and CEO sold 58,677 shares at $8.13 ($477,044)
  19. 4 Open-market sale President and CEO sold 820 shares at $7.30 ($5,986)
  20. 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)

Page 3 of 27 · 526 filings